These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 36739271)

  • 21. Dramatic increases in blood glutamate concentrations are closely related to traumatic brain injury-induced acute lung injury.
    Bai W; Zhu WL; Ning YL; Li P; Zhao Y; Yang N; Chen X; Jiang YL; Yang WQ; Jiang DP; Chen LY; Zhou YG
    Sci Rep; 2017 Jul; 7(1):5380. PubMed ID: 28710466
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Orally Administered Cinnamon Extract Attenuates Cognitive and Neuronal Deficits Following Traumatic Brain Injury.
    Qubty D; Rubovitch V; Benromano T; Ovadia M; Pick CG
    J Mol Neurosci; 2021 Jan; 71(1):178-186. PubMed ID: 32901372
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CORM-3 ameliorates neurodegeneration in the amygdala and improves depression- and anxiety-like behavior in a rat model of combined traumatic brain injury and hemorrhagic shock.
    Li Y; Zhang LM; Zhang DX; Zheng WC; Bai Y; Bai J; Fu L; Wang XP
    Neurochem Int; 2020 Nov; 140():104842. PubMed ID: 32858089
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of blood glutamate scavengers oxaloacetate and pyruvate on neurological outcome in a rat model of subarachnoid hemorrhage.
    Boyko M; Melamed I; Gruenbaum BF; Gruenbaum SE; Ohayon S; Leibowitz A; Brotfain E; Shapira Y; Zlotnik A
    Neurotherapeutics; 2012 Jul; 9(3):649-57. PubMed ID: 22711471
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of traumatic brain injury with 17α-ethinylestradiol-3-sulfate in a rat model.
    Kim H; Yu T; Cam-Etoz B; van Groen T; Hubbard WJ; Chaudry IH
    J Neurosurg; 2017 Jul; 127(1):23-31. PubMed ID: 27662529
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Glutamate Neurotransmission in Rodent Models of Traumatic Brain Injury.
    Dorsett CR; McGuire JL; DePasquale EA; Gardner AE; Floyd CL; McCullumsmith RE
    J Neurotrauma; 2017 Jan; 34(2):263-272. PubMed ID: 27256113
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pyruvate's blood glutamate scavenging activity contributes to the spectrum of its neuroprotective mechanisms in a rat model of stroke.
    Boyko M; Zlotnik A; Gruenbaum BF; Gruenbaum SE; Ohayon S; Kuts R; Melamed I; Regev A; Shapira Y; Teichberg VI
    Eur J Neurosci; 2011 Nov; 34(9):1432-41. PubMed ID: 21936878
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Morphine attenuates neuroinflammation and blood-brain barrier disruption following traumatic brain injury through the opioidergic system.
    Rahimi S; Dadfar B; Tavakolian G; Asadi Rad A; Rashid Shabkahi A; Siahposht-Khachaki A
    Brain Res Bull; 2021 Nov; 176():103-111. PubMed ID: 34464684
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Resuscitation from experimental traumatic brain injury by agmatine therapy.
    Kuo JR; Lo CJ; Chio CC; Chang CP; Lin MT
    Resuscitation; 2007 Dec; 75(3):506-14. PubMed ID: 17629391
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of human mesenchymal stem cell treatment to prevent anhedonia in a rat model of traumatic brain injury.
    Darkazalli A; Ismail AA; Abad N; Grant SC; Levenson CW
    Restor Neurol Neurosci; 2016 Apr; 34(3):433-41. PubMed ID: 27080073
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The contribution of the blood glutamate scavenging activity of pyruvate to its neuroprotective properties in a rat model of closed head injury.
    Zlotnik A; Gurevich B; Cherniavsky E; Tkachov S; Matuzani-Ruban A; Leon A; Shapira Y; Teichberg VI
    Neurochem Res; 2008 Jun; 33(6):1044-50. PubMed ID: 18080187
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Post-traumatic administration of the p53 inactivator pifithrin-α oxygen analogue reduces hippocampal neuronal loss and improves cognitive deficits after experimental traumatic brain injury.
    Yang LY; Greig NH; Huang YN; Hsieh TH; Tweedie D; Yu QS; Hoffer BJ; Luo Y; Kao YC; Wang JY
    Neurobiol Dis; 2016 Dec; 96():216-226. PubMed ID: 27553877
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Traumatic brain injury causes long-term behavioral changes related to region-specific increases of cerebral blood flow.
    Pöttker B; Stöber F; Hummel R; Angenstein F; Radyushkin K; Goldschmidt J; Schäfer MKE
    Brain Struct Funct; 2017 Dec; 222(9):4005-4021. PubMed ID: 28589257
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Postinjury weight rather than cognitive or behavioral impairment predicts development of posttraumatic epilepsy after lateral fluid-percussion injury in rats.
    Lapinlampi N; Andrade P; Paananen T; Hämäläinen E; Ekolle Ndode-Ekane X; Puhakka N; Pitkänen A
    Epilepsia; 2020 Sep; 61(9):2035-2052. PubMed ID: 32786029
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dietary therapy restores glutamatergic input to orexin/hypocretin neurons after traumatic brain injury in mice.
    Elliott JE; De Luche SE; Churchill MJ; Moore C; Cohen AS; Meshul CK; Lim MM
    Sleep; 2018 Mar; 41(3):. PubMed ID: 29315422
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neuroprotective Effects of the Glutamate Transporter Activator (R)-(-)-5-methyl-1-nicotinoyl-2-pyrazoline (MS-153) following Traumatic Brain Injury in the Adult Rat.
    Fontana AC; Fox DP; Zoubroulis A; Mortensen OV; Raghupathi R
    J Neurotrauma; 2016 Jun; 33(11):1073-83. PubMed ID: 26200170
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pomalidomide mitigates neuronal loss, neuroinflammation, and behavioral impairments induced by traumatic brain injury in rat.
    Wang JY; Huang YN; Chiu CC; Tweedie D; Luo W; Pick CG; Chou SY; Luo Y; Hoffer BJ; Greig NH; Wang JY
    J Neuroinflammation; 2016 Jun; 13(1):168. PubMed ID: 27353053
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-lasting blood-brain barrier dysfunction and neuroinflammation after traumatic brain injury.
    van Vliet EA; Ndode-Ekane XE; Lehto LJ; Gorter JA; Andrade P; Aronica E; Gröhn O; Pitkänen A
    Neurobiol Dis; 2020 Nov; 145():105080. PubMed ID: 32919030
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ectoderm-derived frontal bone mesenchymal stem cells promote traumatic brain injury recovery by alleviating neuroinflammation and glutamate excitotoxicity partially via FGF1.
    Qin Q; Wang T; Xu Z; Liu S; Zhang H; Du Z; Wang J; Wang Y; Wang Z; Yuan S; Wu J; He W; Wang C; Yan X; Wang Y; Jiang X
    Stem Cell Res Ther; 2022 Jul; 13(1):341. PubMed ID: 35883153
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Glutamate receptor antibodies in neurological diseases: anti-AMPA-GluR3 antibodies, anti-NMDA-NR1 antibodies, anti-NMDA-NR2A/B antibodies, anti-mGluR1 antibodies or anti-mGluR5 antibodies are present in subpopulations of patients with either: epilepsy, encephalitis, cerebellar ataxia, systemic lupus erythematosus (SLE) and neuropsychiatric SLE, Sjogren's syndrome, schizophrenia, mania or stroke. These autoimmune anti-glutamate receptor antibodies can bind neurons in few brain regions, activate glutamate receptors, decrease glutamate receptor's expression, impair glutamate-induced signaling and function, activate blood brain barrier endothelial cells, kill neurons, damage the brain, induce behavioral/psychiatric/cognitive abnormalities and ataxia in animal models, and can be removed or silenced in some patients by immunotherapy.
    Levite M
    J Neural Transm (Vienna); 2014 Aug; 121(8):1029-75. PubMed ID: 25081016
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.